SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. on May 30, 2023, reporting an event that occurred on May 23, 2023. The registrant is an emerging growth company incorporated in Delaware, with its principal executive offices in Fort Mill, SC. The filing addresses a regulatory compliance issue regarding its listing on the NYSE American.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a listing status event and does not contain financial statement data.
Material Changes
The material change reported is the Company's failure to comply with NYSE American continued listing standards. Specifically, the Company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, by the extended due date of May 22, 2023. Consequently, the Company received a notice from NYSE Regulation on May 23, 2023, citing non-compliance with Section 1007 of the NYSE American Company Guide.
Outlook, Risks, and Management Commentary
Management has issued a press release (Exhibit 99.1) acknowledging the delisting notice. The primary risk identified is the potential loss of listing status on the NYSE American due to the failure to meet timely filing criteria. No forward-looking guidance or financial outlook is provided in this specific filing.
Investor Verification Checklist
- Verify the current status of the Form 10-Q for the quarter ended March 31, 2023, and whether it has been subsequently filed.
- Confirm the Company's current listing status on the NYSE American and any deadlines for reinstatement.
- Review the attached press release (Exhibit 99.1) for details on the Company's remediation plan.
- Check for any subsequent filings that may address the delisting notice or provide updated financial data.